Related Experiment Video
Updated: Jun 16, 2026
05:55
Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats
Published on: September 27, 2024
Mechanical vibration preserves bone structure in rats treated with glucocorticoids
Mônica Longo de Oliveira1, Cássia T Bergamaschi, Orivaldo Lopes Silva
1Division of Endocrinology, Federal University of São Paulo, Brazil. modl@terra.com.br
Bone
|February 16, 2010
Summary
Low-intensity mechanical vibration partially prevented bone loss caused by glucocorticoids in rats. This vibration therapy improved bone structure and bone volume, offering a potential strategy against drug-induced osteoporosis.
Area of Science:
- Biomedical Engineering
- Orthopedics
- Pharmacology
Background:
- Glucocorticoids are a primary cause of secondary osteoporosis, leading to reduced bone quality and increased fracture risk.
- Mechanical stimulation, specifically low-intensity, high-frequency vibration, shows promise in preventing bone loss and promoting bone formation.
Purpose of the Study:
- To investigate the effects of mechanical vibration on bone structure in rats undergoing glucocorticoid treatment.
Main Methods:
- Thirty male Wistar rats were divided into control, glucocorticoid (methylprednisolone), and glucocorticoid with vibration groups.
- Vibration therapy involved a 60 Hz frequency and 1 G acceleration for 30 minutes daily, 5 days/week for 9 weeks.
- Bone mass (DXA), fracture load, histomorphometry, and bone volume were assessed.
Main Results:
- Glucocorticoids significantly reduced weight gain, bone mineral content, and trabecular number, while increasing trabecular spacing.
- Vibration partially preserved trabecular number and reduced trabecular spacing compared to the glucocorticoid group.
- Vibration significantly augmented tibia bone volume compared to controls.
Conclusions:
- Low-intensity, high-frequency mechanical vibration can partially counteract the negative effects of glucocorticoids on bone structure.
- Mechanical vibration therapy presents a potential therapeutic approach for managing glucocorticoid-induced bone loss.
